Eribulin Injection

Eribulin Injection is a medication used in the treatment of certain types of cancer. It is specifically indicated for the treatment of metastatic breast cancer and liposarcoma. Eribulin belongs to a class of drugs called microtubule inhibitors, which work by interfering with the growth and spread of cancer cells.

Eribulin is administered as an intravenous (IV) injection, meaning it is given directly into a vein. The dosage and frequency of administration will depend on various factors, including the type and stage of cancer being treated, as well as the patient's overall health.

It is important to note that Eribulin Injection should only be used under the supervision of a qualified healthcare professional, as it can cause serious side effects. Common side effects may include fatigue, nausea, hair loss, and low white blood cell count. Your healthcare provider will closely monitor you during treatment to manage any potential side effects.

It is always recommended to consult with your healthcare provider for more specific information about Eribulin Injection and its potential benefits and risks in your particular situation.